OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure: a cross-over study.
Published in:
Diabetic Medicine, 2001, v. 18, n. 8, p. 614, doi. 10.1046/j.1464-5491.2001.00528.x
By:
- Lalej-Bennis, D.;
- Boillot, J.;
- Bardin, C.;
- Zirinis, P.;
- Coste, A.;
- Escudier, E.;
- Chast, F.;
- Peynegre, R.;
- Selam, J-L.;
- Slama, G.
Publication type:
Article
Lispro insulin is suitable for external pumps but not for implantable pumps.
Published in:
1998
By:
- Demirdjian, Sylvie;
- Bardin, Christophe;
- Savin, Sandrine;
- Zirinis, Phédon;
- Chast, François;
- Slama, Gerard;
- Sélam, Jean-Louis;
- Demirdjian, S;
- Bardin, C;
- Savin, S;
- Zirinis, P;
- Chast, F;
- Slama, G;
- Sélam, J L
Publication type:
commentary
STUDIES ON S-ADENOSYLHOMOCYSTEINE INHIBITION OF HISTAMINE TRANSMETHYLATION IN BRAIN.
Published in:
Journal of Neurochemistry, 1973, v. 20, n. 1, p. 13, doi. 10.1111/j.1471-4159.1973.tb12099.x
By:
- Baudry, M.;
- Chast, F.;
- Schwartz, J.-C.
Publication type:
Article
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.
Published in:
British Journal of Cancer, 2006, v. 95, n. 3, p. 253, doi. 10.1038/sj.bjc.6603265
By:
- Lévy, V.;
- Zohar, S.;
- Bardin, C.;
- Vekhoff, A.;
- Chaoui, D.;
- Rio, B.;
- Legrand, O.;
- Sentenac, S.;
- Rousselot, P.;
- Raffoux, E.;
- Chast, F.;
- Chevret, S.;
- Marie, J. P.
Publication type:
Article

Found: 4

Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure: a cross-over study.

Lispro insulin is suitable for external pumps but not for implantable pumps.

STUDIES ON S-ADENOSYLHOMOCYSTEINE INHIBITION OF HISTAMINE TRANSMETHYLATION IN BRAIN.

A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.